Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial

Alexa B Kimball; Francisco Kerdel; David Adams; Ulrich Mrowietz; Joel M Gelfand; Robert Gniadecki; Errol P Prens; Joel Schlessinger; Christos C Zouboulis; Hessel H van der Zee; Marie Rosenfeld; Parvez Mulani; Yihua Gu; Susan Paulson; Martin Okun; Gregor Jemec

doi:10.7326/0003-4819-157-12-201212180-00004

Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial

Alexa B Kimball, Francisco Kerdel, David Adams, Ulrich Mrowietz, Joel M Gelfand, Robert Gniadecki, Errol P Prens, Joel Schlessinger, Christos C Zouboulis, Hessel H van der Zee, Marie Rosenfeld, Parvez Mulani, Yihua Gu, Susan Paulson, Martin Okun, Gregor Jemec

Department of Dermatology

409 Citations (Scopus)

Abstract

Hidradenitis suppurativa (HS) is a chronic, painful skin disease characterized by abscesses, nodules, and draining fistulas in the axilla and groin of young adults.

Original language	English
Journal	Annals of Internal Medicine
Volume	157
Issue number	12
Pages (from-to)	846-55
Number of pages	10
ISSN	0003-4819
DOIs	https://doi.org/10.7326/0003-4819-157-12-201212180-00004
Publication status	Published - 2012

Access to Document

10.7326/0003-4819-157-12-201212180-00004

http://www.ncbi.nlm.nih.gov/pubmed/23247938

Cite this

Kimball, A. B., Kerdel, F., Adams, D., Mrowietz, U., Gelfand, J. M., Gniadecki, R., Prens, E. P., Schlessinger, J., Zouboulis, C. C., van der Zee, H. H., Rosenfeld, M., Mulani, P., Gu, Y., Paulson, S., Okun, M., & Jemec, G. (2012). Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial. Annals of Internal Medicine, 157(12), 846-55. https://doi.org/10.7326/0003-4819-157-12-201212180-00004

Kimball, AB, Kerdel, F, Adams, D, Mrowietz, U, Gelfand, JM, Gniadecki, R, Prens, EP, Schlessinger, J, Zouboulis, CC, van der Zee, HH, Rosenfeld, M, Mulani, P, Gu, Y, Paulson, S, Okun, M & Jemec, G 2012, 'Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial', Annals of Internal Medicine, vol. 157, no. 12, pp. 846-55. https://doi.org/10.7326/0003-4819-157-12-201212180-00004

@article{f7ffd9c2e50b4ac5b79f217583bd4d15,

title = "Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial",

abstract = "Hidradenitis suppurativa (HS) is a chronic, painful skin disease characterized by abscesses, nodules, and draining fistulas in the axilla and groin of young adults.",

author = "Kimball, \{Alexa B\} and Francisco Kerdel and David Adams and Ulrich Mrowietz and Gelfand, \{Joel M\} and Robert Gniadecki and Prens, \{Errol P\} and Joel Schlessinger and Zouboulis, \{Christos C\} and \{van der Zee\}, \{Hessel H\} and Marie Rosenfeld and Parvez Mulani and Yihua Gu and Susan Paulson and Martin Okun and Gregor Jemec",

year = "2012",

doi = "10.7326/0003-4819-157-12-201212180-00004",

language = "English",

volume = "157",

pages = "846--55",

journal = "Annals of Internal Medicine",

issn = "0003-4819",

publisher = "American College of Physicians",

number = "12",

}

TY - JOUR

T1 - Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa

T2 - a parallel randomized trial

AU - Kimball, Alexa B

AU - Kerdel, Francisco

AU - Adams, David

AU - Mrowietz, Ulrich

AU - Gelfand, Joel M

AU - Gniadecki, Robert

AU - Prens, Errol P

AU - Schlessinger, Joel

AU - Zouboulis, Christos C

AU - van der Zee, Hessel H

AU - Rosenfeld, Marie

AU - Mulani, Parvez

AU - Gu, Yihua

AU - Paulson, Susan

AU - Okun, Martin

AU - Jemec, Gregor

PY - 2012

Y1 - 2012

N2 - Hidradenitis suppurativa (HS) is a chronic, painful skin disease characterized by abscesses, nodules, and draining fistulas in the axilla and groin of young adults.

AB - Hidradenitis suppurativa (HS) is a chronic, painful skin disease characterized by abscesses, nodules, and draining fistulas in the axilla and groin of young adults.

UR - https://www.scopus.com/pages/publications/84871353413

U2 - 10.7326/0003-4819-157-12-201212180-00004

DO - 10.7326/0003-4819-157-12-201212180-00004

M3 - Journal article

C2 - 23247938

SN - 0003-4819

VL - 157

SP - 846

EP - 855

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

IS - 12

ER -

Adalimumab for the treatment of moderate to severe Hidradenitis suppurativa: a parallel randomized trial

Abstract

Access to Document

Other files and links

Fingerprint

Cite this